DK1749534T3 - Anvendelse af parasitære biologiske midler til forebyggelse og kontrol af inflammatorisk tarmsygdom - Google Patents

Anvendelse af parasitære biologiske midler til forebyggelse og kontrol af inflammatorisk tarmsygdom

Info

Publication number
DK1749534T3
DK1749534T3 DK06021312.1T DK06021312T DK1749534T3 DK 1749534 T3 DK1749534 T3 DK 1749534T3 DK 06021312 T DK06021312 T DK 06021312T DK 1749534 T3 DK1749534 T3 DK 1749534T3
Authority
DK
Denmark
Prior art keywords
prevention
control
inflammatory bowel
bowel disease
biological agents
Prior art date
Application number
DK06021312.1T
Other languages
English (en)
Inventor
Joel Weinstock
David E Elliott
Original Assignee
Univ Iowa Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Iowa Res Found filed Critical Univ Iowa Res Found
Application granted granted Critical
Publication of DK1749534T3 publication Critical patent/DK1749534T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/855—Proteins from animals other than mammals or birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Transplantation (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK06021312.1T 1997-12-31 1998-12-11 Anvendelse af parasitære biologiske midler til forebyggelse og kontrol af inflammatorisk tarmsygdom DK1749534T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7014797P 1997-12-31 1997-12-31
EP98963124A EP1041994A4 (en) 1997-12-31 1998-12-11 USE OF PARASITIC BIOLOGICALS FOR PREVENTING AND CONTROLLING AUTOIMMUNE DISEASES

Publications (1)

Publication Number Publication Date
DK1749534T3 true DK1749534T3 (da) 2013-09-02

Family

ID=22093437

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06021312.1T DK1749534T3 (da) 1997-12-31 1998-12-11 Anvendelse af parasitære biologiske midler til forebyggelse og kontrol af inflammatorisk tarmsygdom

Country Status (10)

Country Link
US (3) US6764838B2 (da)
EP (3) EP1041994A4 (da)
JP (3) JP4733830B2 (da)
AU (1) AU740776B2 (da)
CA (1) CA2315790C (da)
DK (1) DK1749534T3 (da)
ES (1) ES2430394T3 (da)
HK (1) HK1100745A1 (da)
PT (1) PT1749534E (da)
WO (1) WO1999033479A1 (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1041994A4 (en) * 1997-12-31 2003-02-19 Univ Iowa Res Found USE OF PARASITIC BIOLOGICALS FOR PREVENTING AND CONTROLLING AUTOIMMUNE DISEASES
GB9824034D0 (en) * 1998-11-03 1998-12-30 Univ Nottingham Immunomodulatory factors forimmunosuppressant and antiallergic treatment
US20050118655A1 (en) * 2003-11-17 2005-06-02 University Of Iowa Research Foundation Use of parasitic biological agents for diseases prevention and control
US20060024333A1 (en) * 2004-07-26 2006-02-02 O'connor Daniel J Use of parasitic biological agents for prevention and control of allergic and other IgE-mediated disorders
BRPI0621304B8 (pt) * 2005-12-30 2021-05-25 Parasite Tech A/S método de isolamento e armazenagem de ovos do verme de porco t. suis
DE102006023906A1 (de) * 2006-05-19 2007-11-22 Ovamed Gmbh Verfahren zum Nachweis der Viabilität
JPWO2008020489A1 (ja) * 2006-08-17 2010-01-07 株式会社ステリック再生医科学研究所 炎症性腸疾患改善剤
GB2447884B (en) * 2007-03-02 2011-10-26 Mark Barnett Treatment for skin disease
EP1977643A1 (de) * 2007-04-02 2008-10-08 Dr. Falk Pharma Gmbh Herstellung einer viablen, lagerfähigen Wurmeiersuspension
WO2008124842A1 (en) * 2007-04-10 2008-10-16 New England Medical Center Hospitals, Inc. Treatments with helminths
EP2123774A1 (de) 2008-05-21 2009-11-25 Dr. Falk Pharma Gmbh Verfahren zur Charakterisierung der biologischen Aktivität von Helminth-Eiern
US20100124574A1 (en) * 2008-06-19 2010-05-20 Parasite Technologies A/S Composition Comprising Parasite Eggs And Methods For Isolation And Storage Of Parasite Eggs
JP5935200B2 (ja) * 2010-10-27 2016-06-15 国立大学法人山口大学 蠕虫性寄生生物由来の免疫賦活剤
WO2012137899A1 (ja) * 2011-04-06 2012-10-11 学校法人麻布獣医学園 2型糖尿病の発症を抑制する寄生虫
RU2486238C1 (ru) * 2011-12-29 2013-06-27 Государственное бюджетное образовательное учреждение высшего профессионального образования "Сибирский государственный медицинский университет" Министерства здравоохранения и социального развития Российской Федерации (ГБОУ ВПО СибГМУ Минздравсоцразвития России) СПОСОБ НАГРУЗКИ ДЕНДРИТНЫХ КЛЕТОК АНТИГЕНОМ ИНФЕКЦИОННОГО ПРОИСХОЖДЕНИЯ Opisthorchis felineus
US9224200B2 (en) 2012-04-27 2015-12-29 Parasite Technologies A/S Computer vision based method for extracting features relating to the developmental stages of Trichuris spp. eggs
WO2014151648A1 (en) * 2013-03-15 2014-09-25 Coronado Biosciences, Inc. Treatment of autoimmune disease using helminthic parasites
GB201402909D0 (en) * 2014-02-19 2014-04-02 Univ Southampton Treating infection
US9603875B1 (en) 2016-01-07 2017-03-28 NeuOva, LLC Method of making a consumable product with purified embryonated Trichuris suis ova
FR3069163B1 (fr) 2017-07-21 2020-07-10 Fondation Mediterranee Infection Extrait aqueux d'un broyat de planaires
US20210228648A1 (en) * 2018-06-04 2021-07-29 Aarhus Universitet Worm products and methods of use
KR102270850B1 (ko) * 2019-11-25 2021-06-28 전남대학교산학협력단 관절염 예방 또는 치료용 약학 조성물
KR102643035B1 (ko) * 2021-05-24 2024-02-29 전남대학교산학협력단 관절염 예방 또는 치료용 약학 조성물

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4158049A (en) * 1976-09-27 1979-06-12 Edna Mcconnell Clark Foundation Antigen fraction of Schistosoma mansoni eggs suitable for testing for schistosomiasis
US4314992A (en) * 1978-11-08 1982-02-09 Bitakaramire Peter K Process for producing fascioliasis vaccine
US4396600A (en) * 1980-12-18 1983-08-02 Gus Gallucci Adult schistosome worm-derived antigenic substance and method of obtaining same
WO1996040717A1 (en) * 1995-06-07 1996-12-19 Nexstar Pharmaceuticals, Inc. High-affinity nucleic acid ligands of cytokines
JP2700088B2 (ja) * 1991-07-25 1998-01-19 房則 濱島 免疫抑制剤
CA2135390A1 (en) * 1992-05-11 1993-11-25 Matthew Moyle Novel neutrophil inhibitors
WO1995024425A1 (en) * 1994-03-11 1995-09-14 Board Of Regents, The University Of Texas System Immunomodulatory trichinella substances
US6066322A (en) * 1995-03-03 2000-05-23 Millennium Pharmaceuticals, Inc. Methods for the treatment of immune disorders
AU5344996A (en) * 1995-03-23 1996-10-08 Governors Of Dalhousie College And University A process of prolonging organ allograft survival
US5882943A (en) * 1996-07-31 1999-03-16 Aldeen; William Erick Filtration apparatus, kit and method for processing parasite samples
EP1041994A4 (en) * 1997-12-31 2003-02-19 Univ Iowa Res Found USE OF PARASITIC BIOLOGICALS FOR PREVENTING AND CONTROLLING AUTOIMMUNE DISEASES
GB9824034D0 (en) * 1998-11-03 1998-12-30 Univ Nottingham Immunomodulatory factors forimmunosuppressant and antiallergic treatment
DE10109844A1 (de) * 2001-03-01 2003-02-27 Forschungszentrum Borstel Zent Immunmodulierende Wirkstoffe aus parasitären Würmern und Verfahren zu deren Isolierung
JP2003132677A (ja) * 2001-10-29 2003-05-09 Mitsubishi Electric Corp 半導体記憶装置
US20050118655A1 (en) * 2003-11-17 2005-06-02 University Of Iowa Research Foundation Use of parasitic biological agents for diseases prevention and control
US20060024333A1 (en) * 2004-07-26 2006-02-02 O'connor Daniel J Use of parasitic biological agents for prevention and control of allergic and other IgE-mediated disorders
BRPI0621304B8 (pt) * 2005-12-30 2021-05-25 Parasite Tech A/S método de isolamento e armazenagem de ovos do verme de porco t. suis
US20100124574A1 (en) * 2008-06-19 2010-05-20 Parasite Technologies A/S Composition Comprising Parasite Eggs And Methods For Isolation And Storage Of Parasite Eggs

Also Published As

Publication number Publication date
US20070298011A1 (en) 2007-12-27
AU1821399A (en) 1999-07-19
EP1749534A2 (en) 2007-02-07
EP1749534A3 (en) 2007-02-21
PT1749534E (pt) 2013-09-13
EP1749534B1 (en) 2013-08-21
US20040202671A1 (en) 2004-10-14
WO1999033479A1 (en) 1999-07-08
US7250173B2 (en) 2007-07-31
HK1100745A1 (en) 2007-09-28
ES2430394T3 (es) 2013-11-20
EP1041994A1 (en) 2000-10-11
AU740776B2 (en) 2001-11-15
EP2255820A1 (en) 2010-12-01
JP2014129390A (ja) 2014-07-10
US20030039666A1 (en) 2003-02-27
JP2001527048A (ja) 2001-12-25
US7833537B2 (en) 2010-11-16
EP1041994A4 (en) 2003-02-19
CA2315790C (en) 2015-10-06
US6764838B2 (en) 2004-07-20
CA2315790A1 (en) 1999-07-08
JP4733830B2 (ja) 2011-07-27
JP2011016840A (ja) 2011-01-27

Similar Documents

Publication Publication Date Title
DK1749534T3 (da) Anvendelse af parasitære biologiske midler til forebyggelse og kontrol af inflammatorisk tarmsygdom
DK0971735T3 (da) Fremgangsmåder og præparater til behandling af inflammatorisk tarmsygdom
DK1003479T3 (da) Fremgangsmåde og sammensætninger til behandling af allergiske senfasereaktioner og inflammatoriske sygdomme
PT1123255E (pt) Coluna de bolhas e sua utilizacao
DE10080052T1 (de) Beratungshilfeverfahren und -einrichtungen
DK0853945T3 (da) Flydende gonadotropinholdige formuleringer
DE69823725D1 (de) Selbstexpandierendes Medizingerät
NO20022974D0 (no) Anvendelse av biologisk aktive vitamin D-forbindelser for forhindring og behandling av inflammatorisk tarmsykdom
NO990296D0 (no) HPPD-genet og inhibitorer
DE69925262D1 (de) Pharmazeutika zur bildgebung der angiogenischen krankheiten
DE69816411D1 (de) Körperfettmessgerät
KR970000230A (ko) 염증성 장 질환을 치료하기 위한 캅파-아편제 작용물질
NO982265D0 (no) Diagnostikk for og mediatoter for inflammatoriske forstyrrelser
DK1106607T3 (da) Uracilforbindelser og anvendelse deraf
PT1194038E (pt) Composicao de quebra do repouso e sua utilizacao
DK1140952T3 (da) Phosphororganiske forbindelser og anvendelse heraf
IS2087B (is) Lyfjasamsetningar af tizoxaníði og nitazoxaníði
DK0991384T3 (da) Vandladningshjælpemiddel
DK0905128T3 (da) Fremgangsmåder og mellemprodukter egnede til fremstilling af antifolater
DK1228026T3 (da) 15-Hydroxyicosatetraensyrerelaterede forbindelser og fremgangsmåde til anvendelse
DK0981349T3 (da) 5-alfa-pregnan-3-beta-ol-20-on-sulfat til behandling af tumorer og CNS sygdomme
IS5814A (is) Ný lyfjafræðileg notkun á NOS lötum
DK1036319T3 (da) Fremgangsmåde til opnåelse af L-dihydroorotsyre og anvendelse deraf
KR970063186U (ko) 이중흄관의 결합장치
DK199801152A (da) Fremgangsmåde til opdræt af svin og svinesti til brug ved udøvelse af fremgangsmåden